Imedex® is an industry leader in providing certified, independent continuing medical education to health care professionals.
Front-line Advancements to be Presented at the 2017 Conference
Great Debates and Updates in Gastrointestinal Malignancies, an interactive, debate-driven, 2-day conference highlighting the most relevant developments in gastrointestinal malignancies will be an unparalleled educational experience for the 250+ healthcare professionals attending March 24-25, 2017 in New York, New York.
As there are currently more than 200 ongoing phase III clinical trials, the field of GI malignancies is continuously evolving. Given the plethora of emerging data and clinical controversies, community oncologists would benefit greatly from expert guidance to resolve several issues in optimizing the management of GI malignancies, including esophageal, gastric, hepatocellular, pancreatic, and colorectal cancers.
Covering the broad continuum of gastrointestinal malignancies, from upper GI cancers to lower GI cancers to rare tumors, faculty and audience discussion will be insightful with a focus on how new information fits into current community practice.
“Great Debates and Updates in Gastrointestinal Malignancies gives practicing oncologists an exceptional platform from which to move forward in effectively treating patients with gastrointestinal cancers,” said Dr. Grothey.
We look forward to seeing you there!
Axel Grothey, MD
David H. Ilson, MD, PhD
Memorial Sloan-Kettering Cancer Center
New York, New York
|Early Registration Deadline||February 2, 2017|
|Discounted Registration Deadline||March 9, 2017|
|Conference Dates||March 24-25, 2017|
For registration inquiries:
Tel.: +1 (678) 242-0906
Toll-free (USA only): +1 (800) 233-0957
Fax: +1 (770) 751-7334